Inhibition of NO-dependent soluble human platelet guanylate cyclase by isatin

   
Severina I.S.1, Schegolev A.Yu.1, Ponomarev G.V.1, Medvedev A.E.1

1. Institute of Biomedical Chemistry, Russian Academy of Medical Sciences
Section: Experimental/Clinical Study
DOI: 10.18097/pbmc20115703300      PubMed Id: 21863743
Year: 2011  Volume: 57  Issue: 3  Pages: 300-307
Isatin (indole-dione-2,3) is an endogenous indole that exhibits a wide spectrum of biological and pharmacological activities. Physiologically relevant concentrations of isatin (ranged from 1 nM to 10 M) did not influence basal activity of soluble human platelet guanylate cyclase (sGC), but caused a bell-shaped inhibition of the NO-activated enzyme. Inhibition of the NO-dependent activation by isatin did not depend on a chemical nature of the NO donors. The inhibitory effects of ODC (a heme-dependent inhibitor of sGC) and isatin were non-additive suggesting that the inhibitory effect of isatin may involve the heme binding domain (possibly heme iron) and experiments with hemin revealed some isatin-dependent changes in its spectrum. Isatin also inhibited sGC activation by the allosteric activator YC-1. It is suggested that the bell shaped inhibition of the NO-dependent activation of sGC by isatin may be attributed to complex interaction of isatin with the heme binding domain and the allosteric YC-1-binding site of sGC.
Download PDF:
Keywords: guanylate cyclase, nitric oxide (NO), isatin
Citation:

Severina, I. S., Schegolev, A. Yu., Ponomarev, G. V., Medvedev, A. E. (2011). Inhibition of NO-dependent soluble human platelet guanylate cyclase by isatin. Biomeditsinskaya khimiya, 57(3), 300-307.
This paper is also available as the English translation: 10.1134/S1990750811030115
References  
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)